| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2014 | CN101861297B Biphenyl carboxylic acids and derivatives thereof |
| 04/23/2014 | CN101805349B Furan-azo- [3,2-g] chromene compound and application thereof |
| 04/23/2014 | CN101801406B Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| 04/23/2014 | CN101790311B Benzylbenzene derivatives and methods of use |
| 04/23/2014 | CN101781283B Thioredoxin reductase inhibiter compounds and preparation method and application thereof |
| 04/23/2014 | CN101754956B Substituted indazole derivatives active as kinase inhibitors |
| 04/23/2014 | CN101703513B Compound sustained-release preparation of aspirin and clopidogrel or pharmaceutically acceptable salt thereof |
| 04/23/2014 | CN101687827B Aminodihydrothiazine derivatives substituted with cyclic groups |
| 04/23/2014 | CN101687825B Desferrithiocin polyether analogues |
| 04/23/2014 | CN101686665B Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 04/23/2014 | CN101657450B Oxazolidinone antibiotic derivatives |
| 04/23/2014 | CN101636145B Long term 24 hour intestinal administration of levodopa/carbidopa |
| 04/23/2014 | CN101511819B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/23/2014 | CN101328117B 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 04/23/2014 | CN101327220B Use of pseudo-ginseng saponin R1 in preparing medicament for treating liver damage |
| 04/23/2014 | CN101229997B 2-methylene-5-substituted methylene cyclopentanone derivatives and uses thereof |
| 04/23/2014 | CN101175735B Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 04/22/2014 | US8704001 Deuterated 2-amino-3-hydroxypropanoic acid derivatives |
| 04/22/2014 | US8703979 Preparation of anticancer-active tricyclic compounds via alkyne coupling reaction |
| 04/22/2014 | US8703970 Compounds having photochemically removable protecting groups based on an electrocyclic reaction between a chromophore attached via an anilide group to a benzothiophene ring |
| 04/22/2014 | US8703968 Compounds from Antrodia cinnamomea and use thereof |
| 04/22/2014 | US8703964 Bendamustine cyclopolysaccharide compositions |
| 04/22/2014 | US8703962 Monocyclic compounds and their use as TRPV1 ligands |
| 04/22/2014 | US8703961 Thiazole derivatives for the treatment of diseases such as cancer |
| 04/22/2014 | US8703958 5-HT2B receptor antagonists |
| 04/22/2014 | US8703957 Phosphonic acid compounds as inhibitors of serine proteases |
| 04/22/2014 | US8703956 Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid |
| 04/22/2014 | US8703955 Process for the resolution of isoquinoline derivatives |
| 04/22/2014 | US8703953 Aryl ether-base kinase inhibitors |
| 04/22/2014 | US8703952 Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline and analogues and intermediates |
| 04/22/2014 | US8703949 Tandem process for preparing N-alkyl morphinans |
| 04/22/2014 | US8703942 Small-molecule Hsp90 inhibitors |
| 04/22/2014 | US8703930 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 04/22/2014 | US8703924 Chitosan composition |
| 04/22/2014 | US8703922 Low-viscosity liquid crystal compound |
| 04/22/2014 | US8703908 Expression and export of angiogenesis inhibitors as immunofusins |
| 04/22/2014 | US8703893 Four branched dendrimer-PEG for conjugation to proteins and peptides |
| 04/22/2014 | US8703829 Therapeutic compounds |
| 04/22/2014 | US8703828 Antimicrobial compositions and methods of use |
| 04/22/2014 | US8703826 Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure |
| 04/22/2014 | US8703825 Compounds, use thereof as medicaments, and method of preparation thereof |
| 04/22/2014 | US8703824 Cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof |
| 04/22/2014 | US8703823 Methods for treatment of migraine and symptoms thereof |
| 04/22/2014 | US8703822 Method for removing undifferentiated and dedifferentiated stem cell |
| 04/22/2014 | US8703821 Dialkyl ether delivery agents |
| 04/22/2014 | US8703820 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 04/22/2014 | US8703819 Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health |
| 04/22/2014 | US8703816 Compound and medical use thereof |
| 04/22/2014 | US8703815 Small molecules that covalently modify transthyretin |
| 04/22/2014 | US8703814 Pharmaceutical and food compositions for preventing or treating diabetes or obesity |
| 04/22/2014 | US8703813 Compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
| 04/22/2014 | US8703812 Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning |
| 04/22/2014 | US8703811 Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase |
| 04/22/2014 | US8703810 Estrogen receptor modulators and uses thereof |
| 04/22/2014 | US8703809 Combination products |
| 04/22/2014 | US8703808 Use of derivatives of indoles for the treatment of cancer |
| 04/22/2014 | US8703807 Azaspirodecanone compounds |
| 04/22/2014 | US8703806 Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents |
| 04/22/2014 | US8703805 Modulators of LXR |
| 04/22/2014 | US8703804 Ryanodine receptor inhibitors and methods relating thereto |
| 04/22/2014 | US8703803 Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 04/22/2014 | US8703802 Process for the preparation of aryl substituted olefinic amines |
| 04/22/2014 | US8703801 Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications |
| 04/22/2014 | US8703800 Nitrate and diazeniumdiolate derivatives of pioglitazone |
| 04/22/2014 | US8703799 Non-competitive NMDA receptor antagonists |
| 04/22/2014 | US8703798 Antifungal and antiparasitic indoloquinoline derivatives |
| 04/22/2014 | US8703796 3H-imidazo [4, 5-B] pyridine-6-carboxamides as anti-inflammatory agents |
| 04/22/2014 | US8703795 Thienopyridine compounds, and methods of use thereof |
| 04/22/2014 | US8703794 Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof |
| 04/22/2014 | US8703793 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 04/22/2014 | US8703792 C-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation |
| 04/22/2014 | US8703790 Bis [O-(14-benzoylaconine-8-yl)] esters |
| 04/22/2014 | US8703788 Polymorph of nilotinib hydrochloride |
| 04/22/2014 | US8703787 Methods of using ALK inhibitors |
| 04/22/2014 | US8703786 Etravirine formulations and uses thereof |
| 04/22/2014 | US8703785 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
| 04/22/2014 | US8703784 Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin |
| 04/22/2014 | US8703783 Purinone derivatives as HM74A agonists |
| 04/22/2014 | US8703782 Substituted indole derivatives |
| 04/22/2014 | US8703781 Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors |
| 04/22/2014 | US8703780 Inhibitors of Bruton's tyrosine kinase |
| 04/22/2014 | US8703779 Preparation of crystalline forms of dihydropyrazolopyrimidinone |
| 04/22/2014 | US8703778 Heterocyclic kinase inhibitors |
| 04/22/2014 | US8703777 Certain chemical entities, compositions and methods |
| 04/22/2014 | US8703776 Agonists of GPR131 and uses thereof |
| 04/22/2014 | US8703775 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 04/22/2014 | US8703774 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 04/22/2014 | US8703773 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/22/2014 | US8703772 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/22/2014 | US8703771 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
| 04/22/2014 | US8703770 Pyridazine carboxamide orexin receptor antagonists |
| 04/22/2014 | US8703769 Use of EGFR inhibitors to prevent or treat obesity |
| 04/22/2014 | US8703768 Nitrogen containing heteroaryl compounds |
| 04/22/2014 | US8703767 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors |
| 04/22/2014 | US8703766 Oxadiazoanthracene compounds for the treatment of diabetes |
| 04/22/2014 | US8703765 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
| 04/22/2014 | US8703764 Combination therapy for dementia, depression and apathy |
| 04/22/2014 | US8703763 Bridged piperidine derivatives |
| 04/22/2014 | US8703762 Method of treating organophosphorous poisoning |
| 04/22/2014 | US8703760 Antiplatelet agent |